DCF — UF HEALTH SHANDS
Enterprise Value: $2.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$2.0B
Enterprise Value
$532.5M
PV of Cash Flows
$1.5B
PV of Terminal Value
$2.4B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.3B | $252.4M | 11.0% | $106.1M | $96.5M |
| Year 2 | $2.4B | $283.7M | 12.0% | $127.1M | $105.0M |
| Year 3 | $2.4B | $316.7M | 13.0% | $149.3M | $112.1M |
| Year 4 | $2.5B | $338.7M | 13.0% | $163.2M | $111.5M |
| Year 5 | $2.6B | $355.4M | 14.0% | $172.9M | $107.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $2.0B. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.104489942708024
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5